MYC and Familial prostate cancer: The present study investigated the synergistic effects of targeted methotrexate-selenium nanostructure containing Myc decoy oligodeoxynucleotides along with X-irradiation exposure and chemotherapy as a combinational therapy on LNCaP prostate cancer cells.